Surgical Management of Carcinomatosis from Colorectal Cancer

ABSTRACT

Until recently, peritoneal carcinomatosis from colorectal cancer was a universally fatal manifestation of this cancer. However, two innovations in treatment have improved outcome for these patients. The new surgical interventions are collectively referred to as peritonectomy procedures. During these procedures, all visible cancer is removed in an attempt to leave the patient with only microscopic residual disease. Perioperative intraperitoneal chemotherapy, the second innovation, is employed to eradicate small-volume residual disease. The intraperitoneal chemotherapy is administered in the operating room with moderate hyperthermia and is referred to as heated intraoperative intraperitoneal chemotherapy. If tolerated, additional intraperitoneal chemotherapy can be administered during the first 5 postoperative days. The use of these combined treatments, cytoreductive surgery and intraperitoneal chemotherapy, improves survival, optimizes quality of life, and maximally preserves function. This article describes the natural history of colorectal cancer with carcinomatosis, the patterns of dissemination within the peritoneal cavity, and the benefits and limitations of intraperitoneal chemotherapy. Peritonectomy procedures are defined and described. Also presented are the mechanics of delivering perioperative intraperitoneal chemotherapy and the clinical assessments used to select patients who will benefit from combined treatment. The results of combined treatment for colorectal carcinomatosis are presented.

KEYWORDS

Peritonectomy - intraperitoneal chemotherapy - mitomycin C - 5-fluorouracil - hyperthermia - peritoneal surface malignancy - colorectal cancer

REFERENCES

• 1 Temple WJ Surgical Techniques and Outcomes. Surgical Oncology Clinics of North America Philadelphia; WB Saunders 2002
• 2 Taylor I. What constitutes good practice in surgical oncology?.  Eur J Surg Oncol. 2001;  27 517-520
• 3 Sugarbaker P H. Peritonectomy procedures.  Ann Surg. 1995;  221 29-42
• 4 Spratt J S, Adcock R A, Sherrill W, Tavathen S. Hyperthermia peritoneal perfusion system in canines.  Cancer Res. 1980;  40 253-255
• 5 Speyer J L, Sugarbaker P H, Collins J M, Dedrick R L, Klecker R W, Myers C E. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.  Cancer Res. 1981;  41 1916-1922
• 6 Koga S, Hamazoe R, Maeta M, Shimizu N, Kanayama H, Osaki Y. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug.  Cancer Res. 1984;  44 1840-1842
• 7 Flessner M F, Dedrick R L, Schultz J S. A distributable model of peritoneal plasma transport: theoretical considerations.  Am J Physiol. 1984;  246 R597-R607
• 8 Sugarbaker P H, Gianola F J, Speyer J L, Wesley R, Barofsky I, Myers C E. Prospective randomized trial of intravenous vs. peritoneal 5-FU in patients with advanced primary colon or rectal cancer.  Semin Oncol. 1985;  12(3 suppl 4) 101-111
• 9 Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C.  Cancer. 1988;  61 232-237
• 10 Fujimoto S, Shrestha R D, Kokubun M et al.. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding.  Ann Surg. 1988;  208 36-41
• 11 Sugarbaker P H, Jablonski K A. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.  Ann Surg. 1995;  221 124-132
• 12 Yonemura Y, Fujimura T, Nishimura G et al.. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination.  Surgery. 1996;  119 437-444
• 13 Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker P H. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer.  Ann Surg. 1998;  228 347-354
• 14 Moran B J, Cecil T D. The etiology, clinical presentation, and management of pseudomyxoma peritonei.  Surg Oncol Clin N Am. 2003;  12 585-603
• 15 Urano M, Kuroda M, Nishimura Y. For the clinical application of thermo-chemotherapy given at mild temperatures.  Int J Hyperthermia. 1999;  15 79-107
• 16 Verwaal V, van Ruth S, de Bree E et al.. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.  J Clin Oncol. 2003;  21 3737-3743
• 17 Gertsch P. A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: similar results, different treatments.  Surg Oncol Clin N Am. 2003;  12 531-541
• 18 Sugarbaker P H, Graves T, DeBruijn E A et al.. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer.  Cancer Res. 1990;  50 5790-5794
• 19 Jacquet P, Averbach A, Stephens A D et al.. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies.  Oncology. 1998;  55 130-138
• 20 Chu D ZJ, Lang N P, Thompson C, Osteen P K, Westbrook K C. Peritoneal carcinomatosis in non-gynecologic malignancy. A prospective study of prognostic factors.  Cancer. 1989;  63 364-367
• 21 Sadeghi B, Arvieux C, Glehen O et al.. Peritoneal carcinomatosis from non-gynecologic malignancies. Results of the EVOCAPE 1 multicentric prospective study.  Cancer. 2000;  88 358-363
• 22 Jayne D G, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer.  Br J Surg. 2002;  89 1545-1550
• 23 Jones T. I want to live!. In: Erdrich L, Kenison K The Best American Short Stories 1993. New York; Houghton Mifflin 1993: 127-145
• 24 Sampson J A. Implantation peritoneal carcinomatosis of ovarian origin.  Am J Pathol. 1931;  7 423-443
• 25 Weiss L. Metastatic inefficiency: causes and consequences.  Cancer Rev. 1986;  3 1-24
• 26 Spratt J S, Edward M, Kubota T, Lindberg R, Tseng M T. Peritoneal carcinomatosis: anatomy, physiology, diagnosis, management.  Curr Probl Cancer. 1986;  10 555-585
• 27 Zoetmulder F AN. Modelstudies over het Colorectale Carcinoom. Amsterdam; Rodopi 1982
• 28 Autio V. The spread of intraperitoneal infection. Studies with Roentgen contrast medium.  Acto Chir Scand. 1964;  36(suppl 321) 5-31
• 29 Meyers M A. Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid.  Am J Roentgenol Radium Ther Nucl Med. 1973;  119 198-206
• 30 Shimotsuma M, Shields J W, Simpson-Morgan M W et al.. Morpho-physiological function and role of omental milky spots as omentum associated lymphoid tissue (OALT) in the peritoneal cavity.  Lymphology. 1993;  26 90-101
• 31 Sugarbaker P H. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In: Sugarbaker PH Peritoneal Carcinomatosis: Principles of Management Boston; Kluwer 1996: 79-100
• 32 Carmignani C P, Sugarbaker T, Bromley C M, Sugarbaker P H. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread.  Cancer Metastasis Rev. 2003;  22 465-472
• 33 Archer A G, Sugarbaker P H, Jelinek J S. Radiology of peritoneal carcinomatosis. In: Sugarbaker PH Peritoneal Carcinomatosis: Principles of Management Boston; Kluwer 1996: 263-288
• 34 Jacquet P, Jelinek J S, Chang D, Koslowe P, Sugarbaker P H. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery.  J Am Coll Surg. 1995;  181 530-538
• 35 Portilla A G, Sugarbaker P H, Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic factors.  World J Surg. 1999;  23 23-29
• 36 Sugarbaker P H. Successful management of microscopic residual disease in large bowel cancer.  Cancer Chemother Pharmacol. 1999;  43(suppl) S15-S25
• 37 Pestieau S R, Sugarbaker P H. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.  Dis Colon Rectum. 2000;  43 1341-1346
• 38 Elias D, Blot F, El Otmany A et al.. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.  Cancer. 2001;  92 71-76
• 39 Witkamp A J, de Bree E, Kaag M M et al.. Extensive cytoreductive surgery followed by intra-operative hyperthermia intraperitoneal chemotherapy with mitomycin C in patients with carcinomatosis of colorectal cancer.  Eur J Surg. 2001;  37 979-984
• 40 Shen P, Levine E A, Hall J et al.. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.  Arch Surg. 2003;  138 26-33
• 41 Glehen O, Mithieux F, Osinsky D et al.. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study.  J Clin Oncol. 2003;  21 799-806
• 42 Verwaal V J, van Ruth S, de Bree E et al.. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal origin.  J Clin Oncol. 2003;  21 3737-3743
• 43 Glehen O, Kwiatkowski F, Sugarbaker P H et al.. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.  J Clin Oncol. 2004;  22 3284-3292
• 44 Sugarbaker P H, Jablonski K A. Prognostic factors of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.  Ann Surg. 1995;  221 124-132
• 45 Stephens A D, Alderman R, Chang D et al.. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique.  Ann Surg Oncol. 1999;  6 790-796
• 46 Gonzalez-Bayon L, Sugarbaker P H, Gonzalez-Moreno S, de Lima Vazquez V, Alves S, Moran B J. Initiation of a program in peritoneal surface malignancy.  Surg Oncol Clin N Am. 2003;  12 741-753
• 47 McQuellon R P, Loggie B W, Fleming R A et al.. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.  Eur J Surg Oncol. 2001;  27 65-73
• 48 Sugarbaker P H. Carcinomatosis, is cure an option?.  J Clin Oncol. 2003;  21 762-764